← Back to Analyst Consensus 
RDY Hold
DR REDDYS LABORATORIES LTD
Current Price —
Implied Upside —
Analysts 42
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 0 reiterations from 1 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 29, 2026 | Citigroup | upgrade | Sell → Buy | — | 54% |
| Jun 5, 2025 | HSBC | upgrade | Hold → Buy | $16.9 | 52% |
| Nov 6, 2024 | Barclays | maintain | Overweight → Overweight | $17 | 53% |
| Jul 30, 2024 | Barclays | maintain | Overweight → Overweight | $87 | 53% |
| May 8, 2024 | Barclays | maintain | Overweight → Overweight | $81 | 53% |
| Jan 29, 2024 | Barclays | maintain | Overweight → Overweight | $80 | 53% |
| Jun 1, 2023 | Barclays | maintain | Overweight → Overweight | $70 | 53% |
| Oct 31, 2022 | Barclays | maintain | — → Overweight | $67 | 53% |
| Oct 25, 2022 | Barclays | maintain | — → Overweight | $66 | 53% |
| Sep 12, 2022 | Barclays | maintain | — → Overweight | $69 | 53% |
| Jul 25, 2022 | Barclays | maintain | — → Overweight | $68 | 53% |
| May 24, 2022 | Barclays | maintain | — → Overweight | $70 | 53% |
| Nov 1, 2021 | Barclays | maintain | — → Overweight | $80 | 53% |
| Feb 2, 2021 | Barclays | upgrade | Equal-Weight → Overweight | $70 | 53% |
| Jan 28, 2020 | CLSA | downgrade | Buy → Outperform | $0 | 54% |
| Jan 9, 2020 | Citigroup | upgrade | Sell → Buy | $0 | 54% |
| Nov 4, 2019 | B of A Securities | downgrade | Buy → Neutral | $0 | 53% |
| Sep 4, 2019 | Credit Suisse | upgrade | Underperform → Outperform | $0 | — |
| Jun 11, 2019 | Barclays | initiate | — → Equal-Weight | $39 | 53% |
| May 20, 2019 | Morgan Stanley | downgrade | Overweight → Equal-Weight | $0 | 54% |
| Nov 1, 2017 | Jefferies | maintain | — → Underperform | $30.51 | 52% |
| Sep 21, 2017 | Morgan Stanley | upgrade | Equal-Weight → Overweight | $0 | 54% |
| Jul 27, 2016 | HSBC | downgrade | Hold → Reduce | $0 | 52% |
| Jul 27, 2016 | Jefferies | downgrade | Hold → Underperform | $0 | 52% |
| Jul 26, 2016 | Credit Suisse | downgrade | Neutral → Underweight | $0 | — |
| May 2, 2016 | Goldman Sachs | initiate | — → Neutral | $0 | 54% |
| Feb 10, 2016 | CLSA | upgrade | Underperform → Buy | $0 | 54% |
| Dec 2, 2015 | Deutsche Bank | initiate | — → Sell | $0 | 57% |
| Feb 15, 2013 | B of A Securities | downgrade | Buy → Neutral | $0 | 53% |
| Dec 12, 2012 | Credit Suisse | upgrade | Neutral → Outperform | $0 | — |
| Jun 28, 2012 | Anand Rathi | upgrade | Hold → Buy | $0 | — |
| Feb 7, 2012 | Credit Suisse | downgrade | Buy → Hold | $0 | — |
Price Target Trend
Jul 3, 2026 Oct 26, 2026
EPS Estimates
0q —
0y —
+1y —
+1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days